Mitogen-Activated Protein Kinases Inhibitors: Potential Therapeutic Agents for Cancer Cachexia.
Department of Oncology, University of Alberta, Edmonton, Alberta, Canada. Vickie.Baracos@albertahealthservices.ca.
Vickie E
VE
Baracos
D001562:Benzimidazoles / Q000627:therapeutic use; D002100:Cachexia / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D045744:Cell Line, Tumor; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
C517975:AZD 6244; D001562:Benzimidazoles; D047428:Protein Kinase Inhibitors; C581313:binimetinib; D020928:Mitogen-Activated Protein Kinases